98 filings
Page 3 of 5
8-K
7wg 1cytabiuvw
22 Feb 23
Entry into a Material Definitive Agreement
6:06am
DEF 14C
r1xijsndnu9do9ml7u
13 Feb 23
Information statement
5:06pm
8-K
bspo6nau16h7
6 Feb 23
Regulation FD Disclosure
5:35pm
PRE 14C
ebg9x wul2e5
2 Feb 23
Preliminary information
4:10pm
EFFECT
s59pu4 40mizqpks
2 Feb 23
Notice of effectiveness
12:15am
424B3
qyv6z1g9vs2kdwb
1 Feb 23
Prospectus supplement
4:30pm
CORRESP
rd9b6f2
30 Jan 23
Correspondence with SEC
12:00am
UPLOAD
yiug17ah
27 Jan 23
Letter from SEC
12:00am
CORRESP
t4f78iv2 tjo
27 Jan 23
Correspondence with SEC
12:00am
8-K
30gifi vqd34xiu
26 Jan 23
Shuttle Pharmaceuticals to Present at Lytham Partners Investor Select Conference on January 31
4:15pm
CORRESP
h7s 89dwz1xvf
25 Jan 23
Correspondence with SEC
12:00am
D
1nlirm bbljogvd0
20 Jan 23
$4.00 mm in securities to be acquired, sold $4.00 mm, 1 investor
4:24pm
8-K
o3kb7e 6xo
12 Jan 23
Shuttle Pharmaceuticals Announces Private Placement of $4.3 Million of Senior Secured Convertible Note and Warrants
4:59pm
8-K
y1lzsn3
19 Dec 22
Submission of Matters to a Vote of Security Holders
3:30pm
S-8
pc7rxiweywsz44blpin8
12 Dec 22
Registration of securities for employees
4:23pm
8-K
ycybttk
7 Dec 22
Regulation FD Disclosure
4:10pm
DEF 14A
l49hnty utu8n0
21 Nov 22
Definitive proxy
5:28pm
10-Q
pn6qu
14 Nov 22
Quarterly report
5:21pm